Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion
Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan
US scientist Wan Fengyi, a Johns Hopkins University professor known for his research on the potential link between gut infections and colon cancer, has moved permanently to China to join Zhejiang University in Hangzhou. His new position as chair professor at the university includes a lab at a national laboratory affiliated with a hospital that develops blood vessel-based devices.
Wan is one of several senior scientists from US institutions who have taken full-time positions at Zhejiang University this year, including Qian Jiang, a Johns Hopkins eye expert, and Lin Fanghua, a mathematician from New York University.
Written by urgent.news from Reuters Business via SCMP's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
